Dr. Avrum Gillespie, MD

Dr. Gillespie practices at Dialysis Clinic Inc. in Philadelphia, Pennsylvania.

Dr. Gillespie's NPI, 1770747016, was assigned on July 16, 2008. Dr. Gillespie graduated from State University of New York Downstate Medical Center in 2004. Dr. Gillespie holds Pennsylvania license MT183925.

Dr. Gillespie's primary practice is Dialysis Clinic Inc., at 2450 W Hunting Park Ave, Philadelphia, PA 19129 in Philadelphia County. The practice phone is (215) 848-3127.

Dr. Gillespie's primary practice is Dialysis Clinic Inc. in Philadelphia, Pennsylvania. Dr. Gillespie is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Gillespie to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gillespie practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gillespie's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gillespie is licensed in Pennsylvania.

CMS data shows 399 Medicare services from Dr. Gillespie across 6 procedure codes in 2024, for 139 Medicare patients. Medicare paid $53,786 for them.

CMS counts 139 Medicare patients who saw Dr. Gillespie in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 5.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gillespie's median patient age at 63, with 48% women.

In 2024, Dr. Gillespie wrote 1,565 Medicare Part D claims for 156 patients. 84% of them were for generic drugs. CMS names the drug for 1,291 of them, across 41 drugs with 11 or more claims each, at $203,228 in total drug cost. In 2023, CMS named 971 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Gillespie for performance year 2024, reported as part of a group. Dr. Gillespie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Gillespie, published from 2011 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Kidney Transplantation, Kidney Failure, Chronic and Renal Dialysis. Dr. Gillespie has published most often in Kidney360. Dr. Gillespie's most frequent co-authors are Crystal A. Gadegbeku, MD, Peter Philip Reese, MD and Gina M. Simoncini, MD.

CMS Open Payments shows 3 general payments to Dr. Gillespie from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Vertex Pharmaceuticals Incorporated paid the most, $122.

Dr. Gillespie graduated from State University of New York Downstate Medical Center in 2004.